European & Developing Countries Clinical Trials Partnership (EDCTP)
نویسندگان
چکیده
منابع مشابه
European & Developing Countries Clinical Trials Partnership (EDCTP)
EDCTP was established by the European Union in 2003. The first EDCTP program ran until 2015 and focused on HIV, tuberculosis (TB) and malaria. It supported numerous clinical trials that aimed to have a significant impact on the diagnosis, treatment and prevention of these diseases. In light of significant unmet medical needs, the scope of EDCTP was extended in 2014, now covering neglected infec...
متن کاملEuropean and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
BACKGROUND European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerland, and Developing Countries, formed to fund acceleration of new clinical trial interventions to fight the human immunodeficiency virus and acquired immune deficiency syndrome (H...
متن کاملTrials in developing countries.
Good clinical trials can be carried out in the developing countries but ethical issues concerning the trials are frequently brought up for international debate. The concern has its own merit but can be amended if investigators (local and international) pay serious attention to these criticisms and work out the way that will most benefit the trial participants. Although scientific progress is im...
متن کاملA New Vision for Clinical Trials in Africa
December 2004 | Volume 1 | Issue 3 | e71 Last year the European Parliament and Council formed the European and Developing Countries Clinical Trials Partnership (EDCTP). The aim of this new funding body, which has a budget of 400 million spread over fi ve years, is a noble one: to fund research in developing countries, particularly in Africa, that contributes to the development of affordable pro...
متن کاملEthical issues in clinical trials in developing countries.
The vertical transmission trials conducted in a variety of developing countries by researchers from more developed countries illustrate a variety of crucial ethical issues. Three crucial issues are the injustice of the use of placebo control groups, the coerciveness of the offer to participate, and the exploitation of Third World countries. This paper examines each of these issues separately. I...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines & Immunotherapeutics
سال: 2017
ISSN: 2164-5515,2164-554X
DOI: 10.1080/21645515.2017.1356649